Physician

Lindsay Hunter, MD

According to 2025 Medicare claims, Lindsay Hunter, MD (NPI: 1427410810) practices medical oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84107-5701.

Hunter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 311 traditional Medicare patients, billed 106,150 HCPCS/CPT codes, and received $1,620,783 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 612 prescription claims across 150 beneficiaries totaling $2,227,196 in drug costs, led by Ibrance (Palbociclib). Open Payments data shows 7 records totaling $149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,666 to $2,227,196. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.